The 33 rating InvestorsObserver gives to Stealth BioTherapeutics Corp (MITO) stock puts it near the bottom of the Biotechnology industry. In addition to scoring higher than 21 percent of stocks in the Biotechnology industry, MITO’s 33 overall rating means the stock scores better than 33 percent of all stocks.
Click Here to get the full Stock Score Report on Stealth BioTherapeutics Corp (MITO) Stock.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 33 means the stock is more attractive than 33 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Stealth BioTherapeutics Corp Stock Today?
Stealth BioTherapeutics Corp (MITO) stock is lower by -7.06% while the S&P 500 is higher by 0.36% as of 11:02 AM on Thursday, Jan 2. MITO is lower by -$0.23 from the previous closing price of $3.26 on volume of 140,350 shares. Over the past year the S&P 500 has risen 18.09% while MITO is lower by -74.75%. MITO lost -$2.96 per share the over the last 12 months.
To see InvestorsObserver's Sentiment Score for Stealth BioTherapeutics Corp click here.
